News-Papers
Testimonial
Video Gallery
Search
Follow us...
Latest
- Melatonin inhibits proliferation, migration, and invasion by inducing ROS-mediated apoptosis via suppression of the PI3K/Akt/mTOR signaling pathway in gallbladder cancer cells
- Melatonin induces the apoptosis and inhibits the proliferation of human gastric cancer cells via blockade of the AKT/MDM2 pathway
- Melatonin Induces Autophagy via Reactive Oxygen Species-Mediated Endoplasmic Reticulum Stress Pathway in Colorectal Cancer Cells
- Melatonin induces apoptosis in cholangiocarcinoma cell lines by activating the reactive oxygen species-mediated mitochondrial pathway
- 5-Azacytidine- and retinoic-acid-induced reprogramming of DCCs into dormancy suppresses metastasis via restored TGF-β-SMAD4 signaling
- Prolactin-activated PAK1 potentiates estrogen response to breast cancer cell epithelial-mesenchymal transition, migration and invasion
- Enhancing [177Lu]Lu-DOTA-TATE therapeutic efficacy in vitro by combining it with metronomic chemotherapeutics
- Somatostatin in oncology, the overlooked evidences
- Targeting cancer stem cells by melatonin: Effective therapy for cancer treatment
- New perspectives in melatonin uses
- Melatonin and its derivative disrupt cancer stem-like phenotypes of lung cancer cells via AKT downregulation
- Effect of Melatonin in Epithelial Mesenchymal Transition Markers and Invasive Properties of Breast Cancer Stem Cells of Canine and Human Cell Lines
- Somatostatin receptor 2A expression in von Hippel-Lindau-related hemangioblastomas
- Pediatric primary cutaneous anaplastic large-cell lymphoma with associated hypovitaminosis D
- In Vitro and In Vivo Effects of Melatonin-Containing Combinations in Human Pancreatic Ductal Adenocarcinoma
- The effect of melatonin on capecitabine-induced hepatic and renal toxicity in rats
- Actions of melatonin in the reduction of oxidative stress. A review
- Prolactin inhibitors in oncology
Most Read
- The Di Bella Method (DBM)
- All-trans-retinoic acid and cancer
- About melatonin - 1996
- Biography
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Somatostatin in oncology, the overlooked evidences
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Bibliography
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- How effective is chemo therapy?
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- Vademecum
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Frequently Asked Questions
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Di Bella Method's improved survival, objective response and performance status in a retrospective observational clinical study on 55 cases of Lymphomas
- Malignant pleural mesothelioma, stage T3-T4 - Consideration of a case study